Results

Total Results: 2,073 records

Showing results for "indication".
Users also searched for: medication reconciliation

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
    January 01, 2011 - with erlotinib orders had a prior cancer diagnosis indicative of its use in lung cancer (a labeled indication … 165.x) in 84 percent of beneficiaries with an order for the biologic, indicative of its labeled indication
  2. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ischemic-stroke-treatment_executive.pdf
    January 01, 2011 - Neurothrombectomy devices in use Company In Clinical Device Class Name FDA Indication Use? … Neurothrombectomy devices in use (continued) Company In Clinical Device Class Name FDA Indication Use
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - For example, in considering a new transcathether cardiac valve in development for a new clinical indication … median progression-free survival benefit of weeks to a benefit of months or years, depending on the indication … However, this estimate assumes pembrolizumab receives an additional indication as first-line treatment … Thus, its use is off-label for this indication. … ; however, another manufacturer continues to develop the Libra device for this indication.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/quality-rating_research.pdf
    November 01, 2011 - No obvious difference was observed in the numbers of discrepancies, providing a first indication that … criteria,” “clear reporting,” “blinded observers,” and “dropout rate <20 percent,” which provided an indication … This may provide an indication that the format of the article presentation (and not the exact amount … rates to >20 percent was a sufficient factor to downgrade 3 “B” quality studies to “C,” providing an indication … However, it should be noted that the 20 percent cutoff point as indication of “large” dropout is arbitrary
  5. effectivehealthcare-admin.ahrq.gov/products/back-pain-imaging/clinician
    November 01, 2017 - There was potential for confounding by clinical indication among study participants: patients who underwent
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
    December 29, 2015 - 6 Because secukinumab is approved for treating plaque psoriasis, its cost is available for that indication … DMARDs, or TNF inhibitor therapy.9 The company submitted global regulatory submissions for an AS indication … , as well as a psoriatic arthritis indication, in 2015.10 In January 2015, the U.S. … as well as an ankylosing spondylitis (AS) indication.10 In January 2015, FDA approved secukinumab … yet approved for treating PsA, no coverage, coding, or payment information is available for this indication
  7. effectivehealthcare-admin.ahrq.gov/products/vte-prophyalaxis/research-protocol
    December 01, 2019 - United States and either are FDA approved for VTE prophylaxis or are being used off label for this indication … aspirin and clopidogrel, as well as the anticoagulant warfarin, which may be used off label for this indication … Table 1: Pharmacologic agents and medical devices approved in the United States for some indication … 30 mg BID (30 mg for renal impairment) Sanofi-Aventis; generic from Sandoz (2010) 1993 Dosing indication
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-evidence-summary_0.pdf
    June 01, 2021 - The most important limitations were weaker observational study designs, rendering them vulnerable to indication
  9. effectivehealthcare-admin.ahrq.gov/products/test-performance-metrics/appendixes
    December 01, 2019 - These values are highly useful for clinical purposes because they give the clinician an indication of
  10. effectivehealthcare-admin.ahrq.gov/products/hypothyroidism-hyperthyroidism-screening-treatment/research-protocol
    December 01, 2019 - Brand Name: Levo-T, Synthroid, Levothroid, Levoxyl, Unithroid); All drugs are FDA-approved for this indication … triiodothyronine (T3); Generic name: Liotrix (Brand name: Thyrolar) Thyrolar is FDA-approved for this indication
  11. effectivehealthcare-admin.ahrq.gov/products/renal-update/research-protocol
    January 01, 2020 - now allow studies in which patients receive renal artery and aortic surgery, as long as the primary indication … e.g., “drive-by” angioplasty during coronary artery angiography, RAS angioplasty done as a secondary indication
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
    March 01, 2011 - United States and either are FDA approved for VTE prophylaxis or are being used off label for this indication … aspirin and clopidogrel, as well as the anticoagulant warfarin, which may be used off label for this indication … , 2012 Table 1: Pharmacologic agents and medical devices approved in the United States for some indication … BID (30 mg for renal impairment) Sanofi-Aventis; generic from Sandoz (2010) 1993 Dosing indication
  13. 8 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
    November 01, 2008 - For unexpected adverse events, for example, confounding by indication may not be as important an issue … Such ―confounding by indication‖ led to the appearance of an apparent association between selective … an important limitation of uncontrolled studies is that it is difficult to evaluate confounding by indication … Assessment and control for confounding by indication in observational studies.
  14. 8 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
    November 01, 2008 - For unexpected adverse events, for example, confounding by indication may not be as important an issue … Such ―confounding by indication‖ led to the appearance of an apparent association between selective … an important limitation of uncontrolled studies is that it is difficult to evaluate confounding by indication … Assessment and control for confounding by indication in observational studies.
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
    March 28, 2019 - Thus, the authors conclude “As this is an observational study, it is susceptible to confounding by indication … #2 Discussion No, the implications are not balanced by a further discussion of confounding by indication … discussion, findings relative to what is known section, regarding the concept of confounding by indication … My biggest concern is that there is little to no mention of confounding by indication. … discussion, findings relative to what is known section, regarding the concept of confounding by indication
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
    August 23, 2010 - Provide a synthesis of the following information: i Indication/patient inclusion criteria ii Type
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - recognizing a confluence, are concurrently investigating the drug’s utility for treating this second indication
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
    April 01, 2013 - Although radiotherapy is not an FDA-approved indication for ESA use, those results were included because
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - mutation occurs in about 70% of patients with CF, giving ivacaftor the potential for a much broader indication … G551S, G970R, G1244E, S1251N, S1255P, or G1349D. 8,9 Thus, ivacaftor may gain a broader patient indication
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-update_research-protocol.pdf
    January 15, 2015 - now allow studies in which patients receive renal artery and aortic surgery, as long as the primary indication … e.g., “drive-by” angioplasty during coronary artery angiography, RAS angioplasty done as a secondary indication

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: